These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24114993)

  • 1. Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.
    Rho O; Kiguchi K; Jiang G; DiGiovanni J
    Mol Carcinog; 2014 Nov; 53(11):871-82. PubMed ID: 24114993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.
    Rho O; Srivastava J; Cho J; DiGiovanni J
    J Invest Dermatol; 2016 Oct; 136(10):2070-2079. PubMed ID: 27349859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Checkley LA; Rho O; Moore T; Hursting S; DiGiovanni J
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1011-20. PubMed ID: 21733825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
    Gen Y; Yasui K; Nishikawa T; Yoshikawa T
    Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.
    Affara NI; Trempus CS; Schanbacher BL; Pei P; Mallery SR; Bauer JA; Robertson FM
    Anticancer Res; 2006; 26(4B):2805-20. PubMed ID: 16886599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion.
    Wilker E; Lu J; Rho O; Carbajal S; Beltrán L; DiGiovanni J
    Mol Carcinog; 2005 Oct; 44(2):137-45. PubMed ID: 16086373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
    Wheeler DL; Ness KJ; Oberley TD; Verma AK
    Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.
    Li Y; Wang X; Yue P; Tao H; Ramalingam SS; Owonikoko TK; Deng X; Wang Y; Fu H; Khuri FR; Sun SY
    J Biol Chem; 2013 May; 288(19):13215-24. PubMed ID: 23536185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
    Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
    BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits skin tumor promotion in overweight and obese mice.
    Checkley LA; Rho O; Angel JM; Cho J; Blando J; Beltran L; Hursting SD; DiGiovanni J
    Cancer Prev Res (Phila); 2014 Jan; 7(1):54-64. PubMed ID: 24196830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.
    Ramakrishnan V; Kimlinger T; Haug J; Painuly U; Wellik L; Halling T; Rajkumar SV; Kumar S
    PLoS One; 2012; 7(11):e50005. PubMed ID: 23185517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2.
    Soares HP; Ming M; Mellon M; Young SH; Han L; Sinnet-Smith J; Rozengurt E
    Mol Cancer Ther; 2015 Apr; 14(4):1014-23. PubMed ID: 25673820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.
    Kiguchi K; Kitamura T; Moore T; Rumi M; Chang HC; Treece D; Ruffino L; Connolly K; DiGiovanni J
    Cancer Prev Res (Phila); 2010 Aug; 3(8):940-52. PubMed ID: 20682802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.
    Du W; Gerald D; Perruzzi CA; Rodriguez-Waitkus P; Enayati L; Krishnan B; Edmonds J; Hochman ML; Lev DC; Phung TL
    Lab Invest; 2013 Oct; 93(10):1115-27. PubMed ID: 23938603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twist1 regulates keratinocyte proliferation and skin tumor promotion.
    Srivastava J; Rho O; Youssef RM; DiGiovanni J
    Mol Carcinog; 2016 May; 55(5):941-52. PubMed ID: 26013710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.
    Yoon SO; Shin S; Karreth FA; Buel GR; Jedrychowski MP; Plas DR; Dedhar S; Gygi SP; Roux PP; Dephoure N; Blenis J
    Mol Cell; 2017 Aug; 67(3):512-527.e4. PubMed ID: 28757207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
    Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.